CLC bio signs agreement with J Craig Venter Institute

CLC bio has signed a strategic collaborative agreement with the J Craig Venter Institute (JCVI), which focuses on genomic research. The accord consists of a multi-year site licence for the entire CLC bio bioinformatics suite of products. The goal is to implement CLC bio's enterprise solution as a scientific platform across all JCVI sites. This enterprise solution will provide different research projects at JCVI with a coherent integration layer and a standardised way of developing custom software and specialised algorithms.

According to Granger Sutton, senior director of informatics, 'JCVI will benefit from implementing this enterprise solution, as it is a full enterprise platform that integrates, supports, and enhances workflows across different technologies and geographical sites. CLC bio's software platform impressed our evaluators with its advanced features and intuitive, user-friendly interface.'

The enterprise solution CLC bio will be implementing at JCVI contains both server structure and support for all major database formats. This ensures a smart and efficient solution for sharing centralised bioinformatics data in a client/server architecture, where the server contains one or more databases and the clients are CLC bio's workbenches.

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets


Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion